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1. Introduction
  In recent years, studies have shown that because of 
antioxidant, anti-inflammatory, anti-atherosclerosis (AS) 
activity of high-density lipoprotein cholesterol (HDL-C), 
it is closely related to the coronary atherosclerotic heart 
disease. With the further research, the anti-AS effect of 
HDL-C is closely related to its binding protein, especially 
the paraoxonase (PON-1)[1]. PON-1 is an arylesterase which 
is related to HDL, it is believed that the PON-1 and its 
gene family play a role in the cardiovascular disease, type 
2 diabetes and other diseases related with As. There are 
at least three members of this family, the latest research 
think that PON-1 is mainly related to lipid metabolism[2]. 
Based on this, this study used the rabbit with coronary 
atherosclerotic as research object, to explor the effect 
of extracardiac fat local transfection PON-1 on coronary 
atherosclerosis formation.
2. Materials and methods
2.1. Materials
  Twenty general New Zealand male white rabbits, weight 
2.0-2.2 kg, aged three months, were provided by the 
Animal Center of the Medicine Laboratory of XX University. 
pEGFP-PON-1 plasmid were constructed and preserved by 
the molecular biology laboratory of the medical college of 
XX University.
 
Objective: To observe the effect on the inhibition of coronary atherosclerosis hardening of the 
paraoxonase gene (PON-1) which transfected to the rabbit epicardial adipose tissue. Methods: 
Rabbit coronary atherosclerosis model was established by high-fat feeding, liposome-
encapsulated recombinant plasmid pEGFP-PON-1 50 毺L was injected to the rabbit pericardial 
cavity, and was harvested 4 weeks after transfection. Results: The epicardial fat transfected 
PON-1 gene had effect on the high lipid level. It significantly increased expression of PON-1 in 
peripheral arterial vascular tissue (P<0.05); and significantly reduced total cholesterol and low-
density lipoprotein cholesterol levels (P<0.05), and the thickness ratio of coronary artery intima/
media (P <0.05). Conclusions: The injection of the PON-1 gene in the pericardial cavity can 
effectively suppress the formation of coronary atherosclerosis.
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2.2. Main reagents
  Liposome (lipofectamine 2000) was purchased from 
Invitrogen Corp., Mouse anti-rabbit PON-1 antibody was 
purchased from Thermo. Fluorescently labeled goat anti-
mouse secondary antibody was purchased from Gene 
Company. The paraoxonase gene ELISA kit was purchased 
from Sigma, USA.
2.3. Grouping and preparation of rabbit coronary 
atherosclerosis model (AS model)
  All rabbits were randomly divided into four groups: Group 
A (control group), Group B (AS model group), Group C (AS 
model + empty plasmid group), Group D (AS model + PON-1 
group), with 5 in each group. The AS models of rabbits were 
established based on the Ishikawa method[3]. The animals 
were raised in separate cage, and were given the diet of fat 
feed formulation (80.5% basic diet + 5% egg yolk powder + 
0.5% cholesterol + 4% lard) respectively[4]. They were allowed 
to drink freely, with continuous feeding for 4 weeks. And 
anesthesia the rabbits after 8 weeks by injecting of 3% 
pentobarbital sodium through the marginal ear vein, and 
the pleural was opened rapidly. A total of 50 毺L of saline 
was injected via pericardial cavity in the control group and 
the AS model group, 50 毺L empty plasmid or PON-1 gene 
in the model + empty plasmid group and AS model + PON-1 
group via pericardial cavity. Chest was opened and the 
adipose tissue of epicardium was extracted, and the rapid 
frozen sections were prepared. The fluorescence microscope 
was used to observe fluorescence intensity, and then to 
make sure that transiently transfection was successfully 
implemented after the injection of pericardial cavity. Then 
all animals were fed with high fat diet for 4 weeks after 
chest closed, the peripheral blood and epicardial fat were 
collected for detection.
 
2.4. Biochemical analysis
  After feeding for 4 weeks, blood samples (2 mL) were 
collected from the ear vein in each experimental group. 
Serum was separated to determine TC, TG, HDL-C and low 
density lipoprotein cholesterol (LDL-C).
2.5. Western blot detection
  Rabbits were anesthetized with pentobarbital sodium again, 
then the chest was opened, tissue of anterior descending of 
the left coronary artery vascular was extracted. They were 
rinsed by normal saline, then dired by the filter paper, put 
into liquid nitrogen and transferred to refrigerator (-80 曟) 
for Western blot. Protein homogenates extract was added into 
epicardial adipose tissue which was stored at -80 曟 , at the 
ratio of 1:9. Total protein was extracted to make the protein 
quantification, then was denatured at 95 曟-100 曟 for 5 
min, and 30 毺g total protein was taken for electrophoresis 
and transmembrane respectively. Mouse anti-rabbit 
PON-1 antibody was added, diluted at 1:1 000, swayed and 
incubated overnight at 4 曟 . After washing, second antibody 
after was added, and diluted at 1:5 000. It was shaked 
and incubated for 1 h avoid light at room temperature. 
The membranes were washed, and were observed under 
fluorescence system scan. With 毬-actin as an internal 
reference, the gray integral value of each strip was recorded. 
The statistical analysis was performed by sample integral 
value / internal reference integral value ratio.
2.6. HE staining
  Rabbit anterior descending branch of the left coronary 
artery was extracted in all groups, fixed in formalin for 1d. 
Paraffin-embedded sections were 5 毺m in slice thickness. 
They underwent HE staining, dehydration, transparent, and 
cementing. Intima-media thickness of the left coronary 
artery was measured, intima-media thickness ratio was 
calculated.
2.7. Statistical analysis
  The result was expressed by mean暲SD. Date were analyzed 
by ANOVA. Single factor analysis of variance was used to 
compare among groups, P<0.05 was regarded as statistical 
significance.
3. Results
3.1. TC, TG, HDL-C, LDL-C level of the rabbit peripheral 
serum
  Compared with the blank group, TC, TG and LDL-C levels 
of the rabbit peripheral blood were significantly increased in 
the high-fat feeding group, while HDL-C was significantly 
reduced (P<0.05); There was no significantly difference in 
TC, TG, HDL-C and LDL-C between the AS model group 
and the AS model + empty plasmid group (P> 0.05), which 
confirmed that the empty plasmid transfection did not affect 
serum TC, TG, HDL-C, LDL-C levels; In AS model + PON-1 
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group and the AS model + empty plasmid group, TC and 
LDL-C levels were significantly decreased (P <0.05) (Table 
1).
Table 1
TC, TG, HDL-C, and LDL-C levels of rabbit peripheral serum (mmol/
L).
Groups TC TG HDL-C LDL-C
Group A 2.85暲0.47 0.39暲0.08 1.59暲0.18 1.15暲0.25
Group B 22.38暲2.82* 0.65暲0.13* 1.05暲0.12* 24.28暲2.35*
Group C 21.89暲3.10* 0.59暲0.14* 1.08暲0.15* 23.96暲2.06*
Group D 19.28暲0.68*吤書 0.58暲0.13* 1.07暲0.14* 21.83暲2.36*吤書
*Compared with group A, P<0.05; 書Compared with group B, P<0.05; 吤
Compared with group C, P<0.05.
3.2. PON-1 levels of the tissue of anterior descending of the 
left coronary artery vascular in each group
   The PON-1 levels of the tissue of anterior descending of 
the left coronary artery vascular were significantly decreased 
in the AS model group (0.97暲0.16) and the AS model + empty 
plasmid group (0.92暲0.15). There was no difference between 
the AS model group and the AS model + empty plasmid 
group (P > 0.05). The PON-1 levels in AS model + PON-1 
group (1.89暲0.24) were significantly higher than the control 
group (1.53暲0.19) and the AS model group and the AS model 
+ empty plasmid group (P <0.05).
3.3. HE staining of anterior descending of the left coronary 
artery vascular in each group
  HE staining showed in the normal group, the endothelium 
of pulmonary vessels were smooth, the endothelial cells 
distributed symmetrically, there was no dysplasia or obvious 
abnormalities. The AS model group and the AS model + 
empty plasmid group showed arrangement disorder in the 
vascular endothelial cells (Figure 1). The intimal thickening 
was significant, intimal/medial thickness ratio were (17.1
暲2.5)% and (17.4暲2.4)%, significantly higher than the ratio 
of normal control group which was 0 (P<0.05). There was no 
statistically significant between the AS model group and 
the AS model + empty plasmid group (P>0.05). The intimal 
and medial thickening were much significant of the AS 
model + PON-1 group than the normal group, intimal/medial 
thickness ratio were (10.5暲1.6)%, significantly higher than 
the ratio of normal control group which was 0 (P<0.05), but 
it was reduced much significantly than the AS model group 
and the AS model + empty plasmid group (P<0.05) (Table 2).
Table 2
Intimal and medial thickness of rabbits left coronary artery in each 
groups.
Groups intimal thickness 
(毺m)
medial thickness 
(毺m)
i n t i m a l / m e d i a l 
thickness ratio (%)
Group A 0 193.5暲11.4 0
Group B 55.3暲4.2 323.6暲23.5 17.1暲2.5*
Group C 58.6暲4.8 335.8暲24.2 17.4暲2.4*
Group D 25.7暲3.0 244.3暲18.8 10.5暲1.6*吤書
*Compared with group A, P<0.05; 書Compared with group B, P<0.05; 吤
Compared with group C, P<0.05.
A B
C
D
Figure 1. Histological changes of rabbit left coronary in each group 
(HE stain, 暳10).
Group A: control group; Group B: AS model group; Group C: Empty 
plasmid group; Group D:PON-1 group.
4. Discussion
  With the development of the study of cardiovascular 
disease, a large number of risk factors have been discovered. 
Although the pathogenesis is yet not clear, the abnormal 
lipid metabolism plays an important role in the process of 
coronary atherosclerosis. Currently more and more research 
concerned about the gene cluster (PON-1) which is located 
at human chromosome 7q21.3-q22.1, among which the 
PON-1 was more closely related to the lipid metabolism. 
PON-1, also known as aryl dialkyl phosphate enzyme, is a 
glycoprotein synthesized in the liver, which combined with 
HDL-C and hydrolyze organic phosphates, aromatic esters, 
lactones, and LDL-C and other lipid peroxides. Therefore 
PON-1 can inhibit the accumulation of a variety of lipid 
peroxides, and it is linked to cardiovascular disease[5]. In 
this study, we intended to improve the local environment 
of coronary PON-1 expression levels by the transfection 
of PON-1 gene in the local epicardial adipose, hoping to 
achieve the purpose of anti-coronary atherosclerosis.
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  Many studies think that the PON-1 gene was closely related 
to atherosclerosis, coronary heart disease and the diabetes, 
and PON-1 is the main component which can determine the 
lipid metabolism capacity and the antioxidant activity[6]. 
The animal studies of mice showed that atherosclerosis is 
not only associated with PON-1 expression, but also related 
to the degree of its activity and the genetic sensitivity of 
mouse[7]. In this study,we allowed plasmid which contain 
the objective PON-1 confined in a closed pericardial, thus it 
can continue to maintain contact with the surrounding tissue 
due to environmental constraints. PON-1 gene transfection 
was successfully observed by the re-examination, Western 
blot analysis discovered that PON-1 gene transfection can 
significantly improve PON-1 levels of the rabbit coronary, 
and can also reduce TC and LDL-C levels effectively, 
alleviate the pathological changes of intimal and medial. 
These results indicated that the increased expression of the 
local PON-1 gene of epicardial fat can suppress coronary 
atherosclerosis. Consider the mechanism of its occurrence 
is mainly based on the fat-vascular regulatory axis theory[8], 
we believe that the endocrine regulation and feedback loop 
exists between the cardiac fat pad tissue and surrounding 
blood vessels( such as coronary artery), thus can interact and 
regulate the formation of atherosclerosis.
  After PON-1 gene successfully transfected the extracardiac 
fat, the PON-1 expression of local fat pad was significantly 
increased. Through the regulation of fat-vascular regulation 
axes, the expression of coronary vessel wall cells and 
intercellular PON-1 were significantly increased. Because 
PON-1 protein can decomposed lipid peroxides of LDL-C, 
it can reduce phagocytosis of the arterial wall macrophages 
to oxidized low-density lipoprotein particle, slow down the 
accumulation of arterial wall lipid. Studies suggest that in 
addition to inhibiting the oxidation of LDL-C, PON-1 protein 
can also combined with the serum HDL, protect the integrity 
of HDL and prevent HDL oxidation. The HDL itself has the 
function of anti-coronary atherosclerosis, so effectively 
maintain of HDL function can clear excess cholesterol of the 
tissue and inhibit the inflammatory reaction so as to against 
coronary atherosclerosis[9,10].
  In summary, increased PON-1 expression levels of the 
epicardial adipose tissue is expected to become a new 
therapeutic approach to the prevention and treatment of 
coronary atherosclerosis. If we can solve the problem of 
local sustained release function of the PON-1 gene, it will 
provide new treatments for the prevention and treatment of 
the coronary atherosclerosis.
Conflict of interest statement
  We declare that we have no conflict of interest.
References 
[1]  Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns 
AL, Idelman G, et al. Proinflammatory phenotype of perivascular 
adipocytes: influence of high-fat feeding. Circ Res 2009; 104(4): 
541-549.
[2] Ye YP, Mo ZC, Yi GH. Paraoxonase genes and atherosclerotic 
research. China Prac Med 2007; 2(31): 133-134.
[3]  Ishikawa Y, Ishii  T, Asuwa N, Masuda S. Absence of 
atherosclerosis evolution in the coronary arterial segment covered 
by myocardial tissue in cholesterol-fed rabbits. Virchows Arch 
1997; 430(2): 163-171. 
[4]  Heart Protection Study Collaborative Group, Emberson J, 
Bennett D, Link E, Parish S, Danesh J,  et al. C-reactive protein 
concentration and the vascular benefits of statin therapy: an 
analysis of 20 536 patients in the Heart Protection Study. Lancet 
2011; 377(9764): 469-476.
[5]  Gao L, Wu ZG. Paraoxonase genes and atherosclerotic oxidative 
stress. China Prac Med 2008; 35(5): 294-296, 311.
[6]  Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular 
disorders: disturbance of the regulatory system consisting of 
humoral and neuronal signals. Circ Res 2007; 101(1): 27-39.
[7]  Miyoshi M, Nakano Y, Sakaguchi T, Ogi H, Oda N, Suenari K, et 
al. Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia 
after arterial balloon-injury in rabbits fed a high-fat diet. 
Hypertens Res 2007; 30(1): 85-91.
[8]  Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda 
N, et al. Role of adiponectin in preventing vascular stenosis. The 
missing link of adipo-vascular axis. J Biol Chem 2002; 277(40): 
37487-37491. 
[9]  Chen XZ, Sun ZQ, Du XL. The role of epicardial fat in coronary 
atherosclerosis. Chin J Experimental Surg 2008; 25(2): 194-196.
[10] Troughton JA, Woodside JV, Yarnell JW. Paraoxonase activity 
and coronary heart disease risk in healthy middle-aged males: the 
PRIME study. Atherosclerosis 2008; 197(2): 556-563.
